Concepedia

Yeejin Jeon

YJ

Statistics

Publications

4

Citations

79

H-Index

4

Active since

2021

Affiliations

Qurient (South Korea)(Current)

Sungkyunkwan University

Wonkwang University

Yeejin Jeon is an author at Qurient (South Korea) specializing in tumor biology, immunology, and tumor immunity.

ORCID

Top concepts

Publications per year

2021–2024

4

Publications

4

Safety, Tolerability, and Pharmacokinetics of Telacebec (Q203), a New Antituberculosis Agent, in Healthy Subjects

Jeongjun Kim, Jin‐Ho Choi, Hwankyu Kang et al. · Antimicrobial Agents and Chemotherapy · 2021 · 37 citations · Full text

A Novel Selective Axl/Mer/CSF1R Kinase Inhibitor as a Cancer Immunotherapeutic Agent Targeting Both Immune and Tumor Cells in the Tumor Microenvironment

Yeejin Jeon, Hwankyu Kang, Yeongin Yang et al. · Cancers · 2022 · 17 citations · Full text

, , +15

Safety, Tolerability, Pharmacokinetics, and Metabolism of Telacebec (Q203) for the Treatment of Tuberculosis: a Randomized, Placebo-Controlled, Multiple Ascending Dose Phase 1B Trial

Jeongjun Kim, Jin‐Ho Choi, Hwankyu Kang et al. · Antimicrobial Agents and Chemotherapy · 2022 · 15 citations · Full text

An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity

DongHoon Yu, Sabrina Wagner, Martin Schütz et al. · Pharmaceutics · 2024 · 10 citations · Full text

Rows per page

1–4 of 4